Clinical Trial

NEXT GEN - PHILIPS OPTIMUS

Name: NEXT GEN - PHILIPS OPTIMUS — clinical trial record (NCT07521735)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.

Protocol Amendment History 2 changes

critical Trial completed 2026-07-16

notable Enrollment increased: 36 -> 46 participants 2026-07-16

Trial Details

NCT Number	NCT07521735
Lead Sponsor	Philips Clinical & Medical Affairs Global
Conditions	Pulse Oximetry
Enrollment	46 participants
Start Date	2026-03-09
Primary Completion	2026-03-31 (estimated)
Study Completion	2026-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-15